Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach
Authors not listed
Icahn School of Medicine at Mount Sinai · 2018
Abstract
This study's main hypothesis is that a delivering a tailored lighting intervention (TLI) will provide a successful means for promoting circadian entrainment and treating metabolic disease and inflammation in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) and Alzheimer's disease and related dementias (ADRD). As such, the proposed studies have the potential to provide important insights into the link between AD/ADRD and type 2 diabetes (T2DM) by identifying the disruption of circadian rhythms as a key component in the metabolic impairment. Preliminary data from ongoing studies demonstrates a beneficial effect of light treatment on sleep and depression. If positive results are observed, the potential also exists to transform the manner in which homes, assisted living facilities, and nursing homes are lighted by delivering a simple, practical, non-pharmacological intervention to promote entrainment, improve sleep, and reduce metabolic disease in AD and mild AD MCI patients. This randomized, placebo-controlled, crossover study involving 60 AD/ADRD patients who live in controlled environments (i.e., assisted living facilities and nursing homes), will investigate whether 8 weeks of exposure to a TLI designed to increase circadian entrainment improves sleep, mood, inflammatory markers, and metabolic control, compared to a control, circadian-inactive light.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2018). Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach. <em>Icahn School of Medicine at Mount Sinai</em>. https://clinicaltrials.gov/study/NCT03777722
Vancouver
Anonymous. Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach. Icahn School of Medicine at Mount Sinai. 2018.
BibTeX
@misc{anon2018LightM,
title = {Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach},
author = {Anonymous},
journal = {Icahn School of Medicine at Mount Sinai},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Icahn School of Medicine at Mount Sinai 2019
Open access · US-GOV
Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach
Ascentys Ltd 2023
Open access · US-GOV
Feasibility Study for the Use of Computer Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Metabolic Brain Disease 2021
Citation only
Metabolic disorder in Alzheimer’s disease
Beijing Friendship Hospital 2015
Open access · US-GOV
Monetary Cost of Alzheimer's Disease in China: Study Protocol for a Cluster Randomized Observational Study
Target PharmaSolutions, Inc. 2025
Open access · US-GOV
An Observational Study of Patients Living With Chronic Neurological Diseases
University of California, San Francisco 2021
Open access · US-GOV